Form EFFECT ZyVersa Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 26, 2024 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leading Maritime Disaster Lawyers Urge Duck-Boat Ban After Today’s Incident Near Boston
- Democratic Republic of Congo Launches Landmark "Invest in the DRC" Advertising Campaign in United States
- ELEKTROS Advances EV Charging Strategy Following Conclusion of Jaguar Land Rover Patent Review
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
